Carl Icahn Gets Bullish On Biotech
Read More:
Investor,
Biotech,
Carl Icahn,
Icahn,
Activist Investor,
Pharmaceutical,
Amylin,
Enzon,
Business News
WHILE THE ECONOMY HAS FLOUNDERED, biotechnology companies have turned in a relatively healthy performance, even seeing gains in the last year while th...
Barron's | Teresa Rivas | Posted 03.05.2009 | Business